OncoCyte Corp
NASDAQ:OCX
OncoCyte Corp
NASDAQ:OCX
Price:
3.16
USD
-1.25%
Market Closed
Market Cap:
$90.4m
Balance Sheet
Balance Sheet Decomposition
OncoCyte Corp
OncoCyte Corp
Balance Sheet Decomposition is not available for
OncoCyte Corp
OncoCyte Corp
Balance Sheet
OncoCyte Corp
OncoCyte Corp
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
8
|
10
|
8
|
8
|
22
|
7
|
36
|
20
|
9
|
9
|
|
| Cash Equivalents |
8
|
10
|
8
|
8
|
22
|
7
|
36
|
20
|
9
|
9
|
|
| Short-Term Investments |
3
|
2
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
1
|
1
|
|
| Total Current Assets |
11
|
13
|
9
|
9
|
23
|
9
|
39
|
26
|
11
|
12
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
4
|
7
|
9
|
11
|
5
|
6
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
4
|
7
|
9
|
11
|
5
|
6
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
0
|
1
|
3
|
4
|
6
|
1
|
|
| Intangible Assets |
1
|
1
|
1
|
0
|
0
|
15
|
91
|
62
|
57
|
15
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
9
|
19
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
11
|
13
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
9
|
19
|
0
|
0
|
0
|
|
| Total Assets |
13
N/A
|
14
+13%
|
10
-29%
|
10
-7%
|
40
+320%
|
55
+39%
|
160
+188%
|
100
-37%
|
75
-25%
|
35
-53%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
0
|
2
|
1
|
1
|
2
|
|
| Accrued Liabilities |
1
|
1
|
1
|
2
|
3
|
5
|
10
|
9
|
6
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
3
|
1
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
3
|
2
|
2
|
0
|
1
|
0
|
2
|
0
|
0
|
|
| Total Current Liabilities |
2
|
4
|
5
|
6
|
4
|
9
|
14
|
12
|
7
|
7
|
|
| Long-Term Debt |
0
|
0
|
1
|
1
|
2
|
2
|
0
|
0
|
0
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
3
|
11
|
80
|
48
|
42
|
40
|
|
| Total Liabilities |
2
N/A
|
5
+100%
|
6
+26%
|
6
+5%
|
9
+48%
|
22
+143%
|
94
+331%
|
61
-36%
|
49
-19%
|
47
-4%
|
|
| Equity | |||||||||||
| Common Stock |
35
|
46
|
60
|
75
|
125
|
157
|
253
|
300
|
315
|
338
|
|
| Retained Earnings |
24
|
35
|
55
|
71
|
94
|
124
|
188
|
261
|
290
|
351
|
|
| Other Equity |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
10
N/A
|
10
-5%
|
4
-56%
|
3
-23%
|
31
+806%
|
34
+9%
|
65
+95%
|
40
-39%
|
26
-35%
|
12
N/A
|
|
| Total Liabilities & Equity |
13
N/A
|
14
+13%
|
10
-29%
|
10
-7%
|
40
+320%
|
55
+39%
|
160
+188%
|
100
-37%
|
75
-25%
|
35
-53%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
2
|
2
|
3
|
4
|
5
|
6
|
8
|
17
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
